Anti-arrhythmic Drugs


Sodium-channel blockers are in Class I.

Beta-blockers are in Class II.

Potassium-channel blockers, Class III.

Calcium-channel blockers are in class IV.

Adenosine is a kind of adenosine. - a supplement of electrolytes (magnesium and potassium salts) - digitalis derivatives (cardiac glycosides) Amiodarone is the most powerful antiarrhythmic drug available. Amiodarone's adverse event profile can be severe, with gastrointestinal side effects being the most common. Dronedarone was the antiarrhythmic medicine with the best tolerability, with the fewest severe adverse effects and a significant reduction in the risk of stroke. In patients without structural heart disease, we use propafenone, flecainide, sotalol, and dronedarone as first-line therapies. Beta-blockers affect predominantly slow-channel tissues (Sino atrial [SA] and atrioventricular [AV] nodes), where they reduce rate of automaticity, slow conduction velocity, and prolong refractoriness. Blood pressure medications known as alpha blockers are a type of blood pressure medication. They work by stopping the hormone norepinephrine from tightening the muscles in the walls of smaller arteries and veins, lowering blood pressure. The blood vessels remain open and relaxed as a result. Blood flow is improved, and blood pressure is reduced as a result.



 


    Related Conference of Anti-arrhythmic Drugs

    October 13-14, 2025

    14th International Conference on Cardiology and Cardiovascular Medicine Research

    Vienna, Austria
    October 20-21, 2025

    39th World Congress on Heart Diseases

    Frankfurt, Germany
    October 20-21, 2025

    36th International Conference on Cardiology and Heart Failure

    Osaka, Japan
    October 22-23, 2025

    12th International Conference on Geriatric Cardiology, Cardiovascular Diseases and Palliative Care

    Paris, France
    November 03-04, 2025

    12th International Conference on Hypertension and Cardiovascular Diseases

    Rome, Italy
    November 13-14, 2025

    6th Global Summit on Heart Congress

    Paris, France
    November 18-19, 2025

    26th International Conference on New Horizons in Cardiology and Cardiologists Education

    Paris, France
    November 19-20, 2025

    35th International Conference on Cardiology and Healthcare

    Tokyo, Japan
    November 19-20, 2025

    7th World Heart Congress

    Tokyo, Japan
    November 24-25, 2025

    36th Annual Cardiologists Conference

    Barcelona, Spain
    November 27-28, 2025

    32nd World Heartcare Summit

    Paris, France
    January 12-13, 2026

    12th International Heart Conference

    Dubai, UAE
    March 18-19, 2026

    15th World Heart Congress

    Paris, France
    March 23-24, 2026

    41st World Cardiology Conference

    London, UK
    March 26-27, 2026

    13th International Conference on Interventional Cardiology

    London,
    April 08-29, 2026

    9th Annual Heart Rhythm Conference

    Vienna, Austria
    April 13-14, 2026

    9th World Heart and Brain Conference

    Tokyo, Japan
    May 14-15, 2026

    5th International Conference on Cardiology

    Rome, Italy
    May 21-22, 2026

    15th World Congress on Cardiology

    London, UK
    May 21-22, 2026

    13th World Congress on Hypertension, Cardiology, Primary Health and Patient Care

    Paris, France
    May 27-28, 2026

    6th World Congress on Congestive Heart Failure & Angina

    Paris, France
    June 15-16, 2026

    7th International Conference on Cardiac Imaging and Diagnostics

    Paris, France
    July 29-30, 2026

    30th World Cardiology Conference

    Paris, France

    Anti-arrhythmic Drugs Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in